Europe Dry Eye Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Antibiotic Drops, Hormone Drops, Artificial Tears (OTC Artificial Tears and Prescription Artificial Tears), and Others] and Type (Prescription Drugs and OTC Drugs)
The Europe dry eye products market is expected to grow from US$ 1,993.06 million in 2021 to US$ 2,781.57 million by 2028. It is estimated to grow at a CAGR of 4.9% from 2021 to 2028.
Growing Geriatric Population
The incidence of dry eye is commonly seen in people aged 65 and above. The geriatric population is increasing rapidly across the region. The older population is becoming a significant social transformation such as depending on the other for financial needs and wellness on the younger people in the present century. Older people are significantly contributing to the development of the medical sector as it helps by offering various innovative techniques to treat older people. Various healthcare companies design their products by focusing on the geriatric population. As the degeneration process among older people is much faster, they are highly prevalent to dry eye conditions. Therefore, the high prevalence of dry eye among the older population is likely to encourage manufacturers to introduce new dry eye products in the market, which, in turn, contributes to the market's growth. The development in the healthcare industry has offered various hi-tech healthcare facilities, allowing increased life expectancy. Countries across the region are adopting new techniques to treat older people safely and effectively. Therefore, the increased quality of life is decreasing the death rates, and the older population is growing significantly all over the region. The growing geriatric population is expected to increase the demand for dry eye products such as artificial tears. These are available over-the-counter (OTC) and can be used as a supplement to natural tears. So, growing geriatric population is expected to drive the market growth.
Market Overview
The Europe dry eye products market includes the consolidated markets for Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany held the largest share of the Europe dry eye products market in 2021. Germany is among the countries that have high numbers of patients who are living with eye disorders. Also, the growing number of older people in the country is anticipated to increase the incidence of dry eye condition. Another leading driver for dry eye market is glaucoma. The incidence of glaucoma in Germany is increasing. For instance, the article “The Prevalence of Glaucoma in Young People” published in 2017 states that the prevalence of juvenile glaucoma was around 0.01%, which was based on history, based study. The prevalence of glaucoma was higher in the 18–40 age group, nearly 0.16%. The prevalence of glaucoma was much higher in adults, which accounted for approximately 1.98%. In addition, the country is experiencing market consolidation in the dry eye products market. For instance, in October 2015, SAARBRÜCKEN, Germany & HEIDELBERG, Germany signed an agreement with Novaliq to launch EvoTears in Europe. Thus, such strategic developments are likely to influence market growth during the forecast period.
Europe Dry Eye Products Market Revenue and Forecast to 2028 (US$ Million)
Europe Dry Eye Products Market Segmentation
The Europe dry eye products market is segmented based on product, type, and country.
Based on product, the Europe dry eye products market is segmented into artificial tears, antibiotic drops, hormone drops, and others. The artificial tears segment held the largest market share in 2021. The artificial tears segment is further bifurcated into OTC artificial tears and prescription artificial tears.
Based on type, the Europe dry eye products market is bifurcated into OTC drugs and prescription drugs. The OTC drugs segment held a larger market share in 2021.
Based on country, the Europe dry eye products market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2021.
AbbVie Inc; Bausch Health Companies Inc.; Johnson and Johnson Services, Inc.; Novartis AG; OASIS Medical; OCuSOFT Inc.; Prestige Consumer Healthcare Inc.; ROHTO Pharmaceutical Co, Ltd.; Santen Pharmaceutical Co., Ltd.; and URSAPHARM Arzneimittel GmbH are among the leading companies operating in the Europe dry eye products market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific E-house market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific E-house market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the E-house market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook